Call  +41 61 926 6040
Fax +41 61 926 6049
Toggle Nav
My Cart
Search
Advanced Search
Account
Settings

Cancer

Toggle Nav

Items 21-30 of 41

Page
per page
Set Descending Direction
  1. CD137 (human):Fc (mouse) (rec.)
    CHI-HF-211CD137
    CHI-HF-211CD137-C100100 µg
    CHF 430.00
    Add to Compare
    Learn More
    CD137 (human):Fc (mouse) (rec.)
  2. CD137 (mouse):Fc (human) (rec.)
    AG-40A-0025
    AG-40A-0025-C05050 µg
    CHF 350.00
    Add to Compare
    Learn More
  3. CD137L, Soluble (mouse) (rec.)
    AG-40A-0020Y
    AG-40A-0020Y-C05050 µg
    CHF 420.00
    Add to Compare
    Learn More
    /
  4. CD40 (human):Fc (human) (rec.)
    AG-40B-0083
    AG-40B-0083-C05050 µg
    CHF 300.00
    AG-40B-0083-30503 x 50 µg
    CHF 600.00
    Add to Compare
    Learn More
  5. DR6 (mouse):Fc (human) (rec.)
    AG-40B-0062
    AG-40B-0062-C05050 µg
    CHF 170.00
    AG-40B-0062-30503 x 50 µg
    CHF 335.00
    Add to Compare
    Learn More
  6. Fas (human):Fc (human) (rec.)
    AG-40B-0082
    AG-40B-0082-C05050 µg
    CHF 300.00
    AG-40B-0082-30503 x 50 µg
    CHF 600.00
    Add to Compare
    Learn More
  7. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Equivalent to MegaLigands
    Add to Compare
    Learn More
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.
  8. FasL, Soluble (human) (rec.)
    AG-40B-0001
    AG-40B-0001-C01010 µg
    CHF 190.00
    AG-40B-0001-30103 x 10 µg
    CHF 385.00
    Add to Compare
    Learn More
  9. Fc (human):BAFF (human) (rec.)
    AG-40B-0120
    AG-40B-0120-C01010 µg
    CHF 230.00
    AG-40B-0120-30103 x 10 µg
    CHF 460.00
    AG-40B-0120-C500500 µg
    CHF 2'400.00
    Add to Compare
    Learn More
    Restoration of the splenic T and B cell architecture in Fc-BAFF injected BAFFdeficient mice. BAFF deficient mice were injected at day 0 with 100mg BAFF (human):Fc (human) (AG-40B-0120) intravenously and at day 14 with 50mg BAFF (human):Fc (human) intraper
  10. Fc (human):FasL, Soluble (human) (rec.)
    AG-40B-0132
    AG-40B-0132-C01010 µg
    CHF 335.00
    AG-40B-0132-30103 x 10 µg
    CHF 670.00
    Add to Compare
    Learn More
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of MegaFasL, Soluble (human) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Pr

Items 21-30 of 41

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.